Shares of Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) have received an average rating of “Moderate Buy” from the nine ratings firms that are presently covering the firm, Marketbeat.com reports. Four investment analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month […]
Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) has received a consensus rating of “Moderate Buy” from the nine brokerages that are presently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year price objective […]
Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the nine ratings firms that are currently covering the company, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12-month […]
Shares of Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) have been given a consensus rating of “Moderate Buy” by the nine analysts that are presently covering the company, MarketBeat reports. Four research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month […]
Cantor Fitzgerald reaffirmed their overweight rating on shares of Health Catalyst (NASDAQ:HCAT – Free Report) in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a $16.00 target price on the stock. Separately, Canaccord Genuity Group reduced their price target on shares of Health Catalyst from $16.00 to $14.00 and […]